BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/30/2019 2:20:33 AM | Browse: 291 | Download: 39
Publication Name World Journal of Clinical Cases
Manuscript ID 45205
Country of Manuscript Source United States
Specialty Medicine, Research and Experimental
Manuscript type Case Report
Article Title Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report
Manuscript Source Invited Manuscript
All Author List Mie Mie Thinn, Chung-Tzu Hsueh and Chung-Tsen Hsueh
Funding Agency and Grant Number
Correspondence To Chung-Tsen Hsueh, MD, PhD, Professor, Division of Medical Oncology and Hematology, Department of Medicine, Loma Linda University, 11175 Campus Street, CSP 11015, Loma Linda, CA92357, United States. chsueh@llu.edu
Keywords Squamous cell carcinoma of head and neck; Epidermal growth factor receptor; Erlotinib; Complete response; Skin rash; Tyrosine kinase inhibitor; Case report
Core Tip We present a patient with recurrent/metastatic squamous cell carcinoma of head and neck who had durable complete response after completion of 6-mo erlotinib treatment. Patient experienced severe skin rash and diarrhea toxicities from erlotinib. The severity of these adverse effects has been shown to be predictors of treatment response from inhibitors of epidermal growth factor receptor.
Citation Thin MM, Hsueh CT, Hsueh CT. Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report. World J Clin Cases 2019; 7(5): 616-622
2018-12-19 06:35
Peer-Review Started
2018-12-20 03:05
To Make the First Decision
2019-01-07 00:25
Return for Revision
2019-01-08 07:08
2019-01-12 01:06
Second Decision
2019-01-29 06:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-01-30 02:20
Articles in Press
2019-01-30 02:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-03-05 07:56
ISSN 2307-8960 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Assistant Editor Xiang Li
Science Editor Fang-Fang Ji (Quit in 2019)
Reviewer Code 03704412, and 00646287
Editorial Director Fang-Fang Ji (Quit in 2019)
Journal Chief Editor
Company Chief Editor Lian-Sheng Ma
Language Editor
Electronic Editor Ying-Na Bian (Quit in 2019)
Responsible Electronic Editor Ying-Na Bian (Quit in 2019)
Responsible Science Editor Jin-Lei Wang
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma
Full Article (PDF) WJCC-7-616.pdf
Full Article (Word) WJCC-7-616.docx
Manuscript File 45205-Review.doc
Answering Reviewers 45205-Answering reviewers.pdf
Audio Core Tip 45205-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 45205-Conflict-of-interest statement.pdf
Copyright License Agreement 45205-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 45205-Informed consent statement.pdf
Peer-review Report 45205-Peer-review(s).pdf
Scientific Misconduct Check 45205-Scientific misconduct check.pdf
Scientific Editor Work List 45205-Scientific editor work list.pdf